Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders
Teresa Joanna Stradomska(Children's Memorial Health Institute), Anna Tylki‐Szymańska(Children's Memorial Health Institute), Małgorzata Syczewska(Children's Memorial Health Institute), Agata Pleskaczyńska(Children's Memorial Health Institute), Elżbieta Ciara(Children's Memorial Health Institute), Piotr Kruczek(Cracow University of Technology), Ewa Jamroz(Medical University of Silesia)
Cited by 25
Related Papers
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
|Orphanet Journal of Rare Diseases|2015|345
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response
|Blood|2011|288
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
|Journal of the American Society of Nephrology|2015|284
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
|Orphanet Journal of Rare Diseases|2011|237
New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre
|Journal of Translational Medicine|2016|233